The toxicology and treatment of injuries from chemical warfare agents

Current Anaesthesia and Critical Care

Volumn 14, Issue 3, 2003, Pages 149-154

  Riley, Bernard ^a  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Chemical warfare agents; Classification; Clinical signs; Toxicology; Treatment

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; ASCORBIC ACID; ATROPINE; BENZODIAZEPINE; BLEACHING AGENT; CHEMICAL COMPOUND; CHEMICAL WARFARE AGENT; CHLORAMPHENICOL; CHLORINE; CHLORMETHINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CYANIDE; EYE DROPS; FULLER EARTH; MESYLIC ACID; MUSCLE RELAXANT AGENT; MUSTARD GAS; NERVE GAS; OXIME; OXYGEN; PHOSGENE; PRALIDOXIME; PYRIDOSTIGMINE; SARIN; SULFADIAZINE SILVER; SUXAMETHONIUM; TABUN; TETRACAINE;

ARMY; BATTLE INJURY; BLISTER; CHEMICAL WARFARE; CLINICAL PRACTICE; HISTORY; HUMAN; INTENSIVE CARE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PUBLICATION; SHORT SURVEY; SYMPTOMATOLOGY; TOXICOLOGY;

EID: 0042921469     PISSN: 09537112     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0953-7112(03)00035-8     Document Type: Article

References (17)

1. Paxman J, Harris R A. Higher Form of Killing: The Secret Story of Chemical and Biological Warfare. New York: Hill and Wang, 1982.
2. Okumura T, Suzuki K, Fukuda A, et al. The Tokyo subway sarin attack: disaster management, Part 2: hospital response. Acad. Emerg. Med. 1998; 5(6): 618-624.
3. Moles T M. Emergency medical services systems and HAZMAT major incidents. Resuscitation 1999; 42: 103-116.
4. Borak J, Sidell F R. Agents of chemical warfare: sulfur mustard. Ann EmergMed 1992; 21: 303-308.
5. Willems J L. Clinical management of mustard gas casualties. Ann Med Milit Belg 1989; 3(Suppl): 1-61.
6. Weinbroum A A, Rudick V, Paret G, Kluger Y, Ben Abraham R. Anaesthesia and critical care considerations in nerve agent warfare trauma casualties. Resuscitation 2000; 47(2): 113-123.
7. Karalliedde L. Organophosphorous poisoning, anaesthesia. Anaesthesia 1999; 54: 1073-1088.
8. Maynard R L, Beswick F W. Organophosphorous compounds as chemical warfare agents. In: Ballantyne B, Marrs T C. (eds.) Clinical and Experimental Toxicology of Organophosphates and Carbamates. Butterworth-Heinemann, Oxford 1992; 373-385.
9. Lotti M. The pathogenesis of organophosphate polyneuropathy. Crit. Rev. Toxicol 1991; 21(6): 465-487.
10. Maynard R L. Toxicology of chemical warfare agents. In: Ballantyne B, Marrs T C, Syversen T. (Eds.), General and Applied Toxicology, Vol. 3, 2nd edn. London: MacMillan 1999; 2092-2095.
11. Nozaki H, Hori S, Shinozawa Y, et al. Secondary exposusre of medical staff to sarin vapor in the emergency room. Inten Care Med 1995; 21(12): 1032-1035.
12. Nozaki H, Hori S, Shinozawa Y et al. Relationship between pupil size and acetylcholinesterase activity in patients exposed to sarin vapor. Inten Care Med 1997; 23(9): 1005-1007.
13. Dawson R M. Review of oximes available for treatment of nerve agent poisoning. J Appl Toxicol 1994; 14: 317-331.
14. Keeler J R, Hurst C G, Dunn M A. Pyridostigmine used as a nerve agent pretreatment under wartime conditions. JAMA 1991; 226(5): 693-695.
15. Everett E D, Overholt E L. Phosgene poisoning. JAMA 1968; 205(4): 243-245.
16. Diller W F. Medicalphosgeneproblems, their possible solution. J Occup Med 1978; 20: 189-193.
17. Vogel S N, Sultan T R, Ten Eyck R P. Cyanide poisoning. Clin Toxicol 1981; 18(3): 367-383.